Hal V. Barron
Hal V. Barron (born 1962) is an American clinician-scientist and drug developer who served as president of research and development at GlaxoSmithKline from March 2018 until 2022, when he resigned in order to join the cellular reprogramming venture Altos Labs in August of that year. Prior to this he served as president of research and development at Calico. He has served as executive vice president, head of global product development, and chief medical officer of Hoffman-La Roche.
Hal V. Barron | |
|---|---|
| Alma mater | Washington University in St. Louis, Yale University, University of California, San Francisco |
| Scientific career | |
| Fields | Physician |
| Institutions | University of California, San Francisco (UCSF), Calico (company), Genentech, Hoffmann-La Roche |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.